This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 341642
Submitted by lobbyist on: July 31, 2013 04:59:57 AM
Accepted by Registrar on: August 16, 2013 10:47:00 AM
Designated Filer Information
Gudaitis, Edward |
6711 Mississauga Rd., Suite 202 | |
Mississauga, ON, L5N 2W3
|
905-363-8008 |
Canada |
Organization Information
Gilead Sciences Canada, Inc. |
Gilead Sciences Canada, Inc. is the Canadian affiliate of Gilead Sciences Inc. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company has a focus within the HIV, Hepatitis, Oncology and Respiratory therapeutic areas. |
6711 Mississauga Rd., Suite 202 | |
Mississauga, ON, L5N 2W3
|
905-363-8013 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
Gilead Sciences Inc. |
333 Lakeside Drive
Foster City, CA 94404 United States of America |
Phone: 650-522-5853 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
July 31, 2013 | |
March 5, 2014 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Meeting with the British Columbia Centre for Excellence in HIV/AIDS (BCCfE) to discuss the provincial listing and reimbursement for HIV medications; meeting with the Pharmaceutical Services Division (PSD) within the Ministry of Health to discuss the provincial listing and reimbursement of medications for the treatment of Cystic Fibrosis and Viral Hepatitis; and meeting with the BC Cancer Agency to discuss the provincial listing and reimbursement of Oncology medications.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Public Agency | Health | July 31, 2013 |